Financials

eClerx Services — What the Numbers Say

Figures converted from INR at historical FX rates — see data/company.json.fx_rates for the rate table. Ratios, margins, and multiples are unitless and unchanged.

eClerx is a debt-free, cash-compounding knowledge-process business that converts nearly all of its profit into cash, earns a high-20s return on equity, and hands the surplus back through repeated buybacks. The investment question is not solvency or cash generation — those are settled. It is whether operating margins, which fell from a COVID-era peak near 26% to about 20%, have genuinely turned, and whether a ~20x earnings multiple fairly prices a business growing revenue north of 20%. This page works through the statements in that order.

One trap to clear first: reported EPS fell 34% in FY2026, yet net profit rose 30%. Both are true — the company issued a 1-for-1 bonus in March 2026, doubling the share count. On a like-for-like post-bonus basis, per-share earnings rose about 33% [1]. Read net income, not the raw EPS line.

The 30-Second Read

Sources: FY2026 consolidated results, Statement of Assets and Liabilities and Cash Flows [2]; reported financials, FY2019–FY2026.

How eClerx earns its money. eClerx runs a single reportable business — data management, analytics and process outsourcing — sold almost entirely to global enterprises billed in US dollars, with North America roughly three-quarters of revenue [3]. It is a people business: staff cost is the dominant expense (~61% of revenue), capital needs are tiny (capex under 3% of sales), and the two swing factors on profitability are employee utilisation and the rupee/dollar rate. Because the cost base is largely in rupees and the revenue in dollars, a weaker rupee flows almost straight to margin.

The Year-Wise Statements

The clean multi-year record. Revenue has compounded at roughly 21% over five years and 16% over three, net profit has nearly tripled since FY2019, and returns on equity have held in the low-to-high 20s throughout — with a visible margin dip in the middle of the window that the rest of the page dissects.

Source: reported consolidated financials FY2019–FY2026, as filed with the exchanges, converted at period-end FX. EBIT is operating profit before other income and finance cost. The reported-EPS column is not comparable across years — a 1:2 bonus (FY2023) and a 1:1 bonus (FY2026) roughly quadrupled the share count over the period, so net profit is the clean growth line. Cash-flow columns begin FY2022 (earlier years not disclosed in the structured feed).

Growth: High Quality, With an FX Kicker

FY2026 revenue rose 17.9% in US-dollar terms (to USD 469 million) and 22% in rupees, EBITDA grew 29% and net profit 30% [4]. The gap between the dollar and rupee growth rates is the FX kicker — a depreciating rupee added roughly four points of reported growth. That matters because it is not repeatable: strip out currency and the underlying business is compounding in the high-teens, which is still strong for a BPM operator but not the 22% the headline suggests.

Source: reported consolidated financials FY2019–FY2026, converted at period-end FX [5].

The step-change in FY2022 (revenue +38%) reflects the full-year consolidation of the Personiv acquisition (US onshore delivery, funded from cash), which lifted goodwill and permanently shifted the delivery mix toward higher-cost onshore work — the seed of the later margin normalisation. Growth since has been broad-based and steady, as the quarterly path shows: eClerx has strung together consistent sequential growth with no single lumpy quarter.

Source: reported quarterly consolidated results, Q1 FY2023–Q4 FY2026, converted at period FX [6].

Concentration is the growth risk. North America is the engine but also the exposure — the business leans heavily on a handful of large US financial-services and technology clients. Geographic mix has tilted further toward North America over the decade, so the durability of growth is really the durability of a concentrated set of anchor relationships.

Source: FY2025 Annual Report, Note 36 Segment Information (geographical revenue), converted at period FX [7].

Margins: The Real Debate — Peak, Normalisation, Recovery

This is where the investment case is decided. Operating margin traced a clear arc: a COVID-era peak near 26% in FY2022 (utilisation high, travel and facility costs suppressed), a grind down to about 20% by FY2025 as costs normalised, wages inflated and the onshore Personiv mix diluted the blend, and then a recovery to 21% in FY2026.

Source: derived from reported consolidated financials FY2019–FY2026 [8].

The recovery's quality matters more than its existence. In Q2 FY2026 management walked through a 400 basis-point sequential jump in EBITDA margin, attributing about 200 bps to FX, roughly 60 bps to delivery (utilisation and onshore/offshore mix) and 10 bps to overheads [9]. So half the recent margin gain is currency, not operating leverage — a tailwind that reverses if the rupee firms. The genuinely durable piece is utilisation, which management ran into the mid-70s before easing to 74% in Q4 [10]. Verdict: margins have troughed, but the FY2026 level flatters the underlying rate.

Earnings Quality: The Cash Is Real

eClerx passes the most important test cleanly — reported profit shows up as cash. Free cash flow has tracked at 80–107% of net income every year, and in FY2026 operating cash flow of about $97 million and free cash flow of $84 million actually exceeded net profit.

Source: reported consolidated cash-flow statements FY2022–FY2026, converted at period-end FX [11].

The one thing to watch inside cash conversion is receivables. FY2026 trade receivables (billed plus unbilled) rose to about $113 million from $92 million — roughly a $25 million working-capital drag — and days-sales-outstanding has been choppy, spiking from 80 to 86 days in Q1 FY2026 on client billing-system changes before recovering to the high-70s [12]. Management flagged no collection risk and the ratio normalised within two quarters, but for a business this cash-generative, DSO is the single number that most quickly signals a change in earnings quality.

Balance Sheet: A Fortress

There is little to debate here. eClerx carries no interest-bearing debt, holds about $78 million of cash plus a further roughly $40 million of liquid treasury investments, and ran a current ratio above 3x at FY2026 year-end [13]. The only balance-sheet items an analyst should actually think about:

• Goodwill of about $50 million (~12% of assets), largely from Personiv; it grows with a weaker rupee (USD-denominated) rather than from new deals, and has never been impaired — but it is the one "soft" asset should client attrition ever bite.
• Lease liabilities of about $43 million — genuine but modest office-lease obligations, the closest thing to leverage on the books.
• A derivative liability that swung to about $17 million as the rupee weakened: eClerx hedges roughly 80% of its US-dollar receivables, which protected margins on the way down but now caps how much of further rupee depreciation it can capture [14].

The balance sheet is a weapon, not a constraint: it funds every buyback and the Personiv-style tuck-in without touching a lender.

Returns and Capital Allocation

Return on equity has sat in the low-to-high 20s for the entire window and printed 27.6% in FY2026, despite the company carrying a large idle cash pile that mathematically depresses ROE — the operating business earns considerably more on the capital it actually uses.

Source: derived from reported consolidated financials FY2019–FY2026 [15].

Because it generates far more cash than it can reinvest in a capital-light model, eClerx returns the surplus almost entirely through buybacks, its stated preferred tool [16]. It pays only a token dividend (₹1 per share proposed for FY2026) and uses bonus issues purely to improve retail liquidity, not to return cash [17]. The recent track record:

Sources: FY2025 Annual Report — $45 million buyback at $33 per share and management's note that about $46 million was returned to shareholders [18] [19]; FY2023 bonus of 1,69,13,215 shares [20]; FY2026 buyback of 6.25 lakh shares extinguished, settled 2 January 2026 [21].

This is disciplined per-share management: shares are repurchased with surplus cash at recurring intervals, and the bonus issues — while they optically slash EPS — do not dilute economic ownership. The buyback at $53 in early FY2026 versus $33 eighteen months earlier also tells you management is willing to pay up as the stock re-rates, which is a mild caution on price sensitivity.

Valuation: Cheapest of the Quality Cohort

Nothing is cheap or dear in isolation, so put eClerx against the India-listed BPM/analytics peers it actually screens with. The striking result: eClerx earns the highest return on equity and among the best margins in the group, yet trades at the lowest earnings multiple.

Source: derived from reported financials and market price of $16.3 on 9 July 2026 (about 9.2 crore post-bonus shares); forward P/E on consensus FY2027 EPS of about $0.89 [22].

Source: latest reported financials for each company; trailing P/E from latest annual EPS and market price. Genpact and EXL Service report in USD and are large-cap NYSE/Nasdaq operators (P/E omitted for clean comparison); the India-listed peers are the true valuation comps. eClerx figures derived as reported.

The read: LatentView (pure analytics, cash-heavy) commands 31x on a lower ROE and margin because it is over-capitalised post-IPO; Firstsource and Datamatics sit at 25–26x on thinner margins; Sagility matches eClerx's multiple with weaker returns. eClerx — best-in-class ROE, top-tier margin, 100%+ cash conversion, net cash — sits at the bottom of the multiple range at ~20x trailing and ~18x forward. Against the global majors, its ~28% ROE rivals EXL's and dwarfs Genpact's. The likely explanations for the discount are client concentration, the FX-flattered margin, and modest float — but on quality-adjusted terms the multiple looks supported-to-cheap rather than stretched. An EV/EBITDA of ~13x and a 5%+ free-cash-flow yield say the same.

The Takeaway

The financials confirm a rare combination for an Indian mid-cap: durable 20%+ revenue growth, ~28% returns on equity, a genuinely debt-free balance sheet, and better-than-1x cash conversion feeding a steady buyback. They contradict the bear's easiest talking point — the "34% EPS decline" is a bonus-issue artefact, not a deterioration. What they leave unsettled is margin durability: FY2026's recovery to a 21% EBIT margin leaned about half on a weak rupee, so the operating rate is softer than the print, and roughly three-quarters revenue concentration in North America keeps the growth quality on probation.

At ~20x trailing earnings with the sector's best returns and cash conversion, the valuation is supported by quality — the discount to peers is the market pricing concentration and FX, not a flaw in the accounts.

The first financial metric to watch is the EBITDA margin ex-currency — specifically, whether utilisation and delivery mix (not the rupee) can hold the margin near 25% (company-defined) if the rupee stops falling. That single line separates a genuine operating-leverage story from an FX mirage, and it is where the next re-rating — up or down — will come from. Track receivables/DSO alongside it as the early-warning gauge on cash quality.